PMRA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Pharma Mar SA

Watchlist Manager

Watchlist

Price: 69.35 EUR -0.36% Market Closed

Market Cap: €1.2B

	Pharma Mar SA F:PMRA	ES
N	NFI Group Inc F:9NF	CA
G	Genesem Inc KOSDAQ:217190	KR
	Delta Group Nyrt F:E8E4	HU
	Spyrosoft SA F:2NP	PL
M	Magnora ASA F:4SM	NO

Profitability Summary

Pharma Mar SA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

93%

Strong 3Y Average Gross Margin

94%

Gross Margin is Increasing

92% > 93%

Healthy Operating Margin

18%

Low 3Y Average Operating Margin

Operating Margin is Increasing

2% > 18%

Healthy Net Margin

26%

Sustainable 3Y Average Net Margin

15%

Net Margin is Increasing

8% > 26%

Exceptional Free Cash Flow Margin

23%

Negative 3Y Average Free Cash Flow Margin

-1%

Free Cash Flow Margin is Increasing

-17% > 23%

Positive ROE

25%

Positive 3Y Average ROE

Positive 3Y Average ROIC

18%

Declining ROIC

848% > 31%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.